Search research articles
Contact Us
Filters
Showing results (241-250 of 519) with videos related to
Page
of 52
Sort By:
Frontiers in Neurology
|
November 23, 2020
Cyclic Vomiting Syndrome in Children
Umberto Raucci, Osvaldo Borrelli, Giovanni Di Nardo, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Zesti Smoke Code 10 (SF-002) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of SmokEz Enviro-23 (SF-006) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
Orphanet Journal of Rare Diseases
|
March 8, 2024
Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children
Anna Fetta, Francesco Toni, Ilaria Pettenuzzo, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Smoke Concentrate 809045 (SF-003) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of SmokEz C-10 (SF-005) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
May 16, 2024
Flavouring Group Evaluation 413 (FGE.413): Naringenin
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
June 1, 2022
Scientific opinion on Prosmoke BW 01
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Fumokomp (SF-009) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
Molecular Genetics and Metabolism
|
March 23, 2026
Efficacy of JAK1/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison
Gemma Marinella, Ylenia Vaia, Davide Politano, et al.
Page
of 52
Search research articles
Search
Showing results (241-250 of 519) with videos related to
Sort By:
Page
of 52
Frontiers in Neurology
|
November 23, 2020
Cyclic Vomiting Syndrome in Children
Umberto Raucci, Osvaldo Borrelli, Giovanni Di Nardo, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Zesti Smoke Code 10 (SF-002) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of SmokEz Enviro-23 (SF-006) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
Orphanet Journal of Rare Diseases
|
March 8, 2024
Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children
Anna Fetta, Francesco Toni, Ilaria Pettenuzzo, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Smoke Concentrate 809045 (SF-003) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of SmokEz C-10 (SF-005) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
May 16, 2024
Flavouring Group Evaluation 413 (FGE.413): Naringenin
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
June 1, 2022
Scientific opinion on Prosmoke BW 01
, Maged Younes, Gabriele Aquilina, et al.
EFSA Journal. European Food Safety Authority
|
November 29, 2023
Scientific opinion on the renewal of the authorisation of Fumokomp (SF-009) as a smoke flavouring Primary Product
, Maged Younes, Gabriele Aquilina, et al.
Molecular Genetics and Metabolism
|
March 23, 2026
Efficacy of JAK1/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison
Gemma Marinella, Ylenia Vaia, Davide Politano, et al.
Page
of 52